Compass Pathways

CMPS · NASDAQ

$11.90+$0.79 (+7.11%)TodayMarket closed · Oct 20, 7:50 PM ET

Prev close $11.11

About CMPS

Compass Pathways Plc is a biotechnology company, which provides mental health care services. The company is headquartered in Altrincham, Cheshire and currently employs 156 full-time employees. The company went IPO on 2020-09-18. The firm is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. The company commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. The company also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Employees: 156
Headquarters: Altrincham, Cheshire
Listed: Sep 18, 2020
Sector: Health Care
Industry: Biotechnology
Website: compasspathways.com

Leadership

Compass Pathways executives
Name	Title	Since	Age
Gino Santini	—	—	68
Kabir Nath	—	2022	60
Teri Loxam	—	—	53
Guy Goodwin	—	—	77
Justin Gover	—	—	54
Jeffrey Jonas	—	—	72
Annalisa Jenkins	—	—	59
Daphne Karydas	—	—	52
Thomas Lonngren	—	—	74
Linda Mcgoldrick	—	—	70
Robert McQuade	—	—	68
David Norton	—	—	73
Wayne Riley	—	—	65

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Compass Pathways suppliers and customers
Company	Relationship	Country	Correlation
Imperial College London	Supplier and customer	GB	—
King's College London	Supplier and customer	GB	—
University of Bristol	Supplier and customer	GB	—
University of the Sciences in Philadelphia	Supplier and customer	US	—
ATAI Life Sciences AG	Supplier and customer	DE	—
Columbia University Medical Center	Supplier and customer	US	—
Maryland Oncology Hematology	Supplier and customer	US	—
Rivendell Investments 2018-2 LLC	Supplier and customer	US	—
Sheppard Pratt Health System, Inc.	Supplier and customer	US	—
University Medical Center of Utrecht	Supplier and customer	NL	—

Similar companies

Companies in the same industry as Compass Pathways

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.